These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 89124)

  • 61. [Clinical pharmacology of oxicams].
    Stochla K; Rewerski W
    Pol Tyg Lek; 1983 Jul; 38(30):933-7. PubMed ID: 6657533
    [No Abstract]   [Full Text] [Related]  

  • 62. [Investigations on the clinical effect of the antirheumatic agent piroxicam (author's transl)].
    Mathies H; Wolff E
    MMW Munch Med Wochenschr; 1980 Jan; 122(3):99-102. PubMed ID: 6767932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Plasma and synovial fluid concentrations of isoxicam in meniscectomized patients.
    Ballerini R; Casini A; Chinol M; Mannucci C; Melani F; Ungar F
    Drugs Exp Clin Res; 1985; 11(8):517-21. PubMed ID: 3841790
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Piroxicam capsules versus suppositories: a pharmacokinetic and clinical trial.
    Aärynen M; Palho J
    Arzneimittelforschung; 1986 Apr; 36(4):744-7. PubMed ID: 3521618
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of antacid and food on the absorption of proquazone (Biarison) in man.
    Ohnhaus EE
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):136-9. PubMed ID: 7380586
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lowering of plasma isoxicam concentrations with acetylsalicylic acid.
    Grace EM; Mewa AA; Sweeney GD; Rosenfeld JM; Darke AC; Buchanan WW
    J Rheumatol; 1986 Dec; 13(6):1119-21. PubMed ID: 3560102
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An evaluation of piroxicam, a new non-steroidal anti-inflammatory agent. A multicentre trial.
    Tweddell ED; Willcocks WA
    S Afr Med J; 1981 Jun; 59(25):915-6. PubMed ID: 7015542
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of piroxicam, meclofenamate, ibuprofen, aspirin, and prostacyclin efficacy in a chronic model of cerebral vasospasm.
    White RP; Robertson JT
    Neurosurgery; 1983 Jan; 12(1):40-6. PubMed ID: 6338410
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of antacid on the bioavailabiity of lithium carbonate.
    Goode DL; Newton DW; Ueda CT; Wilson JE; Wulf BG; Kafonek D
    Clin Pharm; 1984; 3(3):284-7. PubMed ID: 6428800
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetics of isoxicam in man following oral administration.
    Kölle EU; Hengy H; Vollmer KO
    Arzneimittelforschung; 1983; 33(4):582-6. PubMed ID: 6683539
    [No Abstract]   [Full Text] [Related]  

  • 71. Overview on the pharmacokinetics of tenoxicam.
    Guentert TW; Heintz RC; Joly R
    Eur J Rheumatol Inflamm; 1987; 9(2):15-25. PubMed ID: 3329107
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.
    Yasuda S; Higashi S; Murakami M; Tomono Y; Kawaguchi M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):249-53. PubMed ID: 10363624
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pharmacokinetic study of piroxicam following oral and rectal administration].
    Acerbi D; Daccò L; Palummeri E
    Boll Chim Farm; 1983 Sep; 122(9):19S-27S. PubMed ID: 6689401
    [No Abstract]   [Full Text] [Related]  

  • 74. [Biliary excretion of tenoxicam in cholecystectomized patients].
    Tamimura H; Mukaihara S; Mine Y; Yotsumoto F; Setoyama M; Suzuki T; Kuruma I
    Nihon Geka Hokan; 1984 Nov; 53(6):779-85. PubMed ID: 6534309
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacokinetic studies of benoxaprofen after therapeutic doses with a review of related pharmacokinetic and metabolic studies.
    Nash JF; Carmichael RH; Ridolfo AS; Spradlin CT
    J Rheumatol Suppl; 1980; 6():12-9. PubMed ID: 6930483
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Skin reactions to piroxicam (three cases) (author's transl)].
    Faure M; Goujon C; Perrot H; Hermier C; Dorveaux O; Deteix P
    Ann Dermatol Venereol; 1982; 109(3):255-8. PubMed ID: 6214201
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics of tenoxicam in patients with impaired renal function.
    Horber FF; Guentert TW; Weidekamm E; Heizmann P; Descoeudres C; Frey FJ
    Eur J Clin Pharmacol; 1986; 29(6):697-701. PubMed ID: 3709612
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Bioavailability of ketoprofen in man with and without concomitant administration of aluminium phosphate.
    Brazier JL; Tamisier JN; Ambert D; Bannier A
    Eur J Clin Pharmacol; 1981 Mar; 19(4):305-7. PubMed ID: 7286034
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of age and sex on piroxicam disposition.
    Richardson CJ; Blocka KL; Ross SG; Verbeeck RK
    Clin Pharmacol Ther; 1985 Jan; 37(1):13-8. PubMed ID: 3965234
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Piroxicam, a novel anti-inflammatory agent.
    Wiseman EH; Chang YH; Lombardino JG
    Arzneimittelforschung; 1976; 26(7):1300-3. PubMed ID: 12765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.